Ongoing Clinical Trials of PerformTek Precision Biometrics

As part of Valencell’s ongoing commitment to creating true, smart, and fun precision biometrics, the company is continuously validating our technology through internal and external clinical trials.  A recent landmark tied to those principles was the presentation of clinical trials of the PerformTek (formerly V-LINC) continuous heart rate monitoring.  At the 59th Annual Meeting of the American College of Sports Medicine, Meir Magal, Ph.D., FACSM, presented the findings of his

[CONTINUE READING THIS ENTRY]

The latest at Valencell : Milestones in clinical validation studies and a rebranding initiative

We have great news to share from the Valencell team. Today the company announced its licensable fitness sensor technology has reached key milestones, achieving unprecedented validation by an independent study recently presented at this year’s American College of Sports Medicine (ACSM) annual conference and validation testing supported by a National Institute of Health (NIH) Phase II Small Business Innovation Research (SBIR) program.  

[CONTINUE READING THIS ENTRY]

Pages